Visionary pharmacovigilance experts across the world are eager to develop a new global network, to share benefit and risk based intelligence of medicinal products. With the fast spread of globalisation, cross-borders & trade-blocs, medical practitioners and drug manufacturers are force to adopting holistic strategies to battle the increasing pressure from their stake holders. The humble aim of GLC's 3rd Annual Pharmacovigilance Forum, is to provide a platform for these practitioners in the hope of finding the answers to some of the pressing issues they face nowadays.
Be the first to uncover the first experiences of complete transition from DDPS to PSMF. Listen to industry experts discussing ready-made and tested solutions to transparency issues in ADR. Discover the correct directions, to adhere to upcoming regulatory deadlines, discussed by its creators, if not by its supporters. Witness the highlight of the event, a participative workshop providing practical insights to overcome inefficiencies and redundancies in PV processes. Meet and greet 20+ industry specialists from global conglomerates such as, Novartis, Pfizer, Abbott, Astellas, Takeda and other experts from the European Medicines Agency, The Royal College of Physicians, and the Drug Safety Research Unit surrounded by a selected senior audience from across Europe.
Coupled with a diversified set of thought leaders and a five star environment, this one of a kind symposium, will link drug manufacturers with the medical practitioners, academia's, PV related associations and governmental representatives from across Europe under one roof.Without a doubt, an exclusive gathering within the PV event space, you cannot afford not to capitalise upon.
Further information can be found at: http://www.globalleadingconferences.com/conferences/pharmacovigilance